Stay updated on Pediatric HIV Triple Therapy Clinical Trial
Sign up to get notified when there's something new on the Pediatric HIV Triple Therapy Clinical Trial page.

Latest updates to the Pediatric HIV Triple Therapy Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record is displayed with its study details, eligibility criteria, outcomes, results, collaborators, publications, and supporting documents.SummaryDifference92%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now returns a 403 Forbidden error, replacing the study details with an error page. A Home link is shown in the header.SummaryDifference23%

- Check57 days agoChange DetectedA new publication reference by McKenna et al. is added to the Publications section (Growth Outcomes After 48 Weeks of Dolutegravir in Children and Adolescents with HIV-1 in IMPAACT); the page revision is updated to v3.7.0.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision moved from v3.6.5 to v3.6.6, indicating a newer revision of the page. This update does not change the study content visible to users.SummaryDifference0.0%

Stay in the know with updates to Pediatric HIV Triple Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric HIV Triple Therapy Clinical Trial page.